Thrombin activatable fibrinolysis inhibitor (TAFI) is not associated with fetal loss, a retrospective study.
Folkeringa
Nienke
N
Division of Haemostasis, Thrombosis and Rheology, University Medical Centre Groningen, The Netherlands. folkeringa@og.umcg.nl
Korteweg
Fleurisca J
FJ
Veeger
Nic J G M
NJ
Middeldorp
Saskia
S
Hamulyak
Karly
K
Prins
Martin H
MH
Erwich
Jan Jaap H M
JJ
Büller
Harry R
HR
van der Meer
Jan
J
D000293:Adolescent; D000328:Adult; D002352:Carrier Proteins / Q000097:blood*; D015331:Cohort Studies; D020964:Embryo Loss / Q000097:blood* / Q000209:etiology* / Q000235:genetics; D005260:Female; D005313:Fetal Death / Q000097:blood* / Q000209:etiology* / Q000235:genetics; D006801:Humans; D008875:Middle Aged; D011247:Pregnancy; D011250:Pregnancy Complications, Hematologic / Q000097:blood* / Q000235:genetics; D012189:Retrospective Studies; D012307:Risk Factors; D019851:Thrombophilia / Q000097:blood* / Q000150:complications* / Q000235:genetics; D054556:Venous Thromboembolism / Q000097:blood / Q000150:complications / Q000235:genetics; D055815:Young Adult
D002352:Carrier Proteins; C426003:ZFYVE1 protein, human